Free · No account required · Powered by AI across the world's largest grants + funders database
Currently focused on US federal, state, and foundation grants.
Antimicrobial Resistance Surveillance in Retail Food Specimens is sponsored by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. The National Antimicrobial Resistance Monitoring System (NARMS) is a U.S. public health surveillance system that tracks antibiotic resistance in enteric bacteria from humans, retail meats, and food animals. When antimicrobial drugs are used in food-producing animals, they can enrich for populations of resistant strains that reach humans via the food supply. The chief goal of the NARMS retail food surveillance program is to improve the detection of and surveillance for antimicrobial resistance among enteric bacteria in raw retail food commodities, particularly fresh retail meat.
The NARMS program is looking to collaborate with institutions or organizations to enhance and strengthen antibiotic resistance surveillance in retail food specimens. Partnering with the NARMS retail food surveillance program will enable the collection of critical data for FDA policy and regulatory actions including but not limited to pre-approval safety evaluation of new animal antibiotics, determining parameters for the antimicrobial use in veterinary medicine, and the ability to provide information to promote interventions to reduce resistance among foodborne bacteria. This collaboration will address NARMS programmatic needs to implement effective surveillance and response for antibiotic resistance as recommended in the National Strategy for Combating Antibiotic-Resistant Bacteria (CARB). This listing is currently active. Program number: 93.876. Last updated on 2022-09-07.
Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information Recent federal obligations suggest $4,416,196 (2023).; eligibility guidance Applicants should review the individual funding opportunity announcement issued under this CFDA program to see which applicant organizations are eligible to apply. Eligible applicant types include: Local (includes State-designated lndian Tribes, excludes institutions of higher education and hospitals, Small business (less than 500 employees), U.S. Territories and possessions (includes institutions of higher education and hospitals), Minority group, Interstate, Native American Organizations (includes lndian groups, cooperatives, corporations, partnerships, associations), Federal, State (includes District of Columbia, public institutions of higher education and hospitals).
Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Based on current listing details, eligibility includes: Applicants should review the individual funding opportunity announcement issued under this CFDA program to see which applicant organizations are eligible to apply. Eligible applicant types include: Local (includes State-designated lndian Tribes, excludes institutions of higher education and hospitals, Small business (less than 500 employees), U.S. Territories and possessions (includes institutions of higher education and hospitals), Minority group, Interstate, Native American Organizations (includes lndian groups, cooperatives, corporations, partnerships, associations), Federal, State (includes District of Columbia, public institutions of higher education and hospitals). Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Recent federal obligations suggest $4,416,196 (2023). Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Arthritis, Musculoskeletal and Skin Diseases Research - Training Individual (TR) is sponsored by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) mission is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; training of basic and clinical scientists to carry out this research; and dissemination of information on research progress in these diseases. The Extramural Program promotes and supports basic, translational, and clinical studies of Systemic Rheumatic and Autoimmune Diseases, Skin Biology and Diseases, Bone Biology and Diseases, Muscle Biology and Diseases, and Joint Biology and Diseases and Orthopaedics. NIAMS Systemic Rheumatic and Autoimmune Diseases programs address basic, translational, and clinical research, including clinical trials and observational and mechanistic studies, focused on immune-mediated arthritis and autoimmune-related acute and chronic disorders in adults and children. NIAMS Skin Biology and Diseases programs support basic, translational, and clinical research in skin, including both common and rare skin diseases. These programs include investigations of the basic molecular, cellular, and developmental biology of skin, as well as studies of skin as an immune, sensory, endocrine, and metabolic organ. NIAMS Bone Biology and Diseases programs support research on the control of bone formation, resorption, and mineralization as well as the effects of signaling molecules on bone cells. They support clinical studies of interventions to prevent fractures associated with osteoporosis and research into less common bone diseases. NIAMS Muscle Biology and Diseases programs encourage research on muscle developmental biology, growth, maintenance, and hypertrophy; physiology of contraction; structural biology of the contractile apparatus; disease mechanisms; biomarkers and outcome measures; and development and clinical testing of therapies for conditions including the muscular dystrophies. NIAMS Joint Biology, Diseases, and Orthopaedics programs support a broad spectrum of research centered on the interplay among the body’s muscles, bones, and connective tissues. They encourage tissue engineering and regenerative medicine research, molecular biology, imaging, and clinical research, and the treatment and prevention of orthopaedic conditions. This listing is currently active. Program number: 93.AR3. Last updated on 2026-01-28. Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information Recent federal obligations suggest $3,765,000 (2026).; eligibility guidance Any candidate(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director/Principal Investigator (PD/PI) is invited to work with their sponsor and organization to develop an application for support. Multiple PDs/PIs are not allowed. By the time of award, the individual must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status). Eligible applicant types include: Unrestricted by Individual Type. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Networking2Save”: CDC’s National Network Approach to Preventing and Controlling Tobacco-related Cancers in Special Populations is sponsored by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. The Office on Smoking and Health and Division of Cancer Prevention and Control seek to build on the progress of the previously funded networks and expand work to address tobacco-and cancer- related health disparities among populations particularly vulnerable to tobacco industry marketing tactics and with higher cancer incidence and death rates. To accelerate the decline in cigarette smoking, address other tobacco use, and reduce the burden of cancer disease and death among the entire population, it will be critical to continue to focus prevention and control efforts on those populations that are most vulnerable and harder to reach with general population interventions. The complex interaction of multiple factors (e.g. socioeconomic status, cultural characteristics, acculturation, stress) and persistent and targeted tobacco industry marketing to these vulnerable populations, contribute to tobacco related disparities. Many factors also contribute to cancer-related disparities such as socioeconomic status, cultural characteristics, diet, and access to healthcare services. This listing is currently active. Program number: 93.431. Last updated on 2026-01-12. Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information Recent federal obligations suggest $6,800,000 (2026).; eligibility guidance Open competition Eligible applicant types include: Unrestricted by Entity Type. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Environmental Health Sciences - Individual Training is sponsored by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. The mission of the National Institute of Environmental Health Sciences (NIEHS) is to research how the environment affects biological systems across the lifespan and to translate this knowledge to reduce disease and promote health. Environmental exposures considered range from chemical, physical, and biologically derived (non-pathogenic) factors humans are exposed to through inhalation, ingestion, or ocular or dermal contact, individually or as mixtures. This listing is currently active. Program number: 93.ESF. Last updated on 2026-01-28. Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information Funding amounts vary by year and recipient.; eligibility guidance Specific eligibility requirements are defined in the NOFO. Eligible applicant types include: Not-for-Profit Organization, Nonprofit Organization. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice.
